PharmGen Science Inc Cash Flow Reinvestment Rate
PharmGen Science Inc cash flow reinvestment rate. PharmGen Science Inc (004720) has a Cash Flow Reinvestment Rate of 0.78x as of September 2025, reinvesting ₩1.48 Billion (capex ₩799.96 Million plus investments ₩-680.92 Million) from operating cash flow of ₩1.91 Billion. See 004720 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of PharmGen Science Inc (2011–2024)
Cash flow reinvestment rate of PharmGen Science Inc from 2011 to 2024. Historical reinvestment intensity for PharmGen Science Inc across 10 annual periods. Explore PharmGen Science Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
PharmGen Science Inc Cash Flow Reinvestment Rate by Year (2011–2024)
PharmGen Science Inc cash flow reinvestment rate by year from 2011 to 2024. Year-by-year capital reinvestment analysis for PharmGen Science Inc. For the full cash flow conversion analysis, see 004720 cash generation efficiency.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.54x | ₩3.67 Billion | ₩2.38 Billion | ₩2.78 Billion | ▲ +74.9% |
| 2023 | 0.88x | ₩4.79 Billion | ₩5.44 Billion | ₩3.29 Billion | ▼ -78.7% |
| 2021 | 4.14x | ₩32.25 Billion | ₩7.78 Billion | ₩30.75 Billion | ▲ +126.7% |
| 2020 | 1.83x | ₩4.89 Billion | ₩2.68 Billion | ₩4.34 Billion | ▼ -55.8% |
| 2019 | 4.14x | ₩10.44 Billion | ₩2.52 Billion | ₩6.16 Billion | ▲ +84.6% |
| 2018 | 2.24x | ₩9.45 Billion | ₩4.22 Billion | ₩892.34 Million | ▲ +161.2% |
| 2017 | 0.86x | ₩1.58 Billion | ₩1.84 Billion | ₩1.54 Billion | ▼ -65.4% |
| 2016 | 2.48x | ₩19.26 Billion | ₩7.75 Billion | ₩3.43 Billion | ▲ +123.6% |
| 2015 | 1.11x | ₩4.02 Billion | ₩3.62 Billion | ₩771.87 Million | ▲ +400.3% |
| 2011 | 0.22x | ₩642.43 Million | ₩2.89 Billion | ₩642.43 Million | — |